Advanced search
Publication Cover
Platelets Volume 33, 2022 - Issue 8
Submit an article Journal homepage
1,607
Views
0
CrossRef citations to date
0
Altmetric
Definitive Report

Inhibition of Src but not Syk causes weak reversal of GPVI-mediated platelet aggregation measured by light transmission aggregometry

Hilaire Yam Fung Cheung1 Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK;2 Department of Bioanalytics, Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V, Dortmund, Germany;3 Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The NetherlandsORCID Iconhttps://orcid.org/0000-0003-0917-5918View further author information
ORCID Icon,
Luis A. Moran1 Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK;4 Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, and Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, SpainORCID Iconhttps://orcid.org/0000-0002-5232-3376View further author information
ORCID Icon,
Albert Sickmann2 Department of Bioanalytics, Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V, Dortmund, GermanyORCID Iconhttps://orcid.org/0000-0002-2388-5265View further author information
ORCID Icon,
Johan W.M. Heemskerk3 Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The NetherlandsORCID Iconhttps://orcid.org/0000-0002-2848-5121View further author information
ORCID Icon,
Ángel Garcia4 Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, and Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, SpainORCID Iconhttps://orcid.org/0000-0003-1176-5917View further author information
ORCID Icon &
Steve P. Watson1 Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7846-7423View further author information
ORCID Icon
Pages 1293-1300 | Received 09 Feb 2022, Accepted 15 Apr 2022, Published online: 09 May 2022

References

  • Watson S, Herbert J, Pollitt AY. GPVI and CLEC‐2 in hemostasis and vascular integrity. J Thromb Haemost 2010;8:1456–1467. doi:10.1111/j.1538-7836.2010.03875.x
  • Ahmed MU, Kaneva V, Loyau S, Nechipurenko D, Receveur N, Le Bris M, Janus-Bell E, Didelot M, Rauch A, Susen S. Pharmacological blockade of glycoprotein VI promotes thrombus disaggregation in the absence of thrombin. Arterioscler Thromb Vasc Biol 2020;40:2127–2142. doi:10.1161/ATVBAHA.120.314301
  • Andre P, Morooka T, Sim D, Abe K, Lowell C, Nanda N, Delaney S, Siu G, Yan Y, Hollenbach S. Critical role for Syk in responses to vascular injury. Blood 2011;118:5000–5010. doi:10.1182/blood-2011-06-360743
  • Mangin PH, Onselaer M-B, Receveur N, Le Lay N, Hardy AT, Wilson C, Sanchez X, Loyau S, Dupuis A, Babar AK. Immobilized fibrinogen activates human platelets through glycoprotein VI. Haematologica 2018;103:898. doi:10.3324/haematol.2017.182972
  • Goto S, Tamura N, Ishida H. Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions. J Am Coll Cardiol 2004;44:316–323. doi:10.1016/j.jacc.2004.02.059
  • Moser M, Bertram U, Peter K, Bode C, Ruef J. Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates. J Cardiovasc Pharmacol 2003;41:586–592. doi:10.1097/00005344-200304000-00011
  • Frojmovic M, Labarthe B, Legrand C. Inhibition and reversal of platelet aggregation by αIIbβ3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamifiban. Br J Haematol 2005;131:348–355. doi:10.1111/j.1365-2141.2005.05782.x
  • Speich H, Earhart A, Hill S, Cholera S, Kueter T, Smith J, White M, Jennings L. Variability of platelet aggregate dispersal with glycoprotein IIb–IIIa antagonists eptifibatide and Abciximab. J Thromb Haemost 2009;7:983–991. doi:10.1111/j.1538-7836.2009.03432.x
  • Zou J, Wu J, Roest M, Heemskerk JW. Long-term platelet priming after glycoprotein VI stimulation in comparison to Protease-Activating Receptor (PAR) stimulation. PloS one 2021;16:e0247425. doi:10.1371/journal.pone.0247425
  • Speich HE, Furman RR, Lands LT, Moodie GD, Jennings LK. Elevating local concentrations of GPIIb–IIIa antagonists counteracts platelet thrombus stability. J Thromb Thrombolysis 2013;36:31–41. doi:10.1007/s11239-012-0814-7
  • Mazharian A, Ghevaert C, Zhang L, Massberg S, Watson SP. Dasatinib enhances megakaryocyte differentiation but inhibits platelet formation. Blood 2011;117:5198–5206. doi:10.1182/blood-2010-12-326850
  • Auger JM, Watson SP. Dynamic tyrosine kinase-regulated signaling and actin polymerisation mediate aggregate stability under shear. Arterioscler Thromb Vasc Biol 2008;28:1499–1504. doi:10.1161/ATVBAHA.108.167296
  • Tullemans B, Heemskerk J, Kuijpers M. Acquired platelet antagonism: off‐target antiplatelet effects of malignancy treatment with tyrosine kinase inhibitors. J Thromb Haemost 2018;16:1686–1699. doi:10.1111/jth.14225
  • Brass LF, Zhu L, Stalker TJ. Novel therapeutic targets at the platelet vascular interface. Arterioscler Thromb Vasc Biol 2008;28:s43–s50. doi:10.1161/ATVBAHA.107.161026
  • Perrella G, Huang J, Provenzale I, Swieringa F, Heubel-Moenen FC, Farndale RW, Roest M, van der Meijden PE, Thomas M, Ariëns RA. Nonredundant roles of platelet glycoprotein VI and integrin αIIbβ3 in fibrin-mediated microthrombus formation. Arterioscler Thromb Vasc Biol 2021;41:e97–e111. doi:10.1161/ATVBAHA.120.314641
  • Montague SJ, Andrews RK, Gardiner EE. Mechanisms of receptor shedding in platelets. Blood 2018;132:2535–2545. doi:10.1182/blood-2018-03-742668
  • Alenazy F, Harbi M, Kavanagh D, Price J, Brady P, Hargreaves O, Harrison P, Slater A, Connolly D, Kirchhof P. GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy. Eur Heart J 2021;42:ehab724. 1425. doi:10.1093/eurheartj/ehab724.1425
  • Baurand A, Eckly A, Bari N, Léon C, Hechler B, Cazenave J-P, Gachet C. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Thromb Haemost 2000;84:484–491. doi:10.1055/s-0037-1614049

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.